Tuesday, May 1, 2012

Ranbaxy Marks World Malaria Day by Unveiling "Indigenously" Developed Anti-Malaria Drug

Indian pharmaceutical giant Ranbaxy announced at a conference in New Delhi that it has developed a new "indigenous" anti-malaria drug.

The new drug, called Synriam, which is effective against the deadliest malaria microbe, Plasmodium Falciparum, would be a boon for millions of malaria patients around the globe, said Ranbaxy chief executive and managing director Arun Sawhney.

No comments: